Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
33
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| O'Reilly Kevin | SVP, President of Oncology Sys | 19 | $0 | $0 | 2021-04-15 |
| Le Beau Michelle | Director | 6 | $0 | $0 | 2021-04-15 |
| Ashkenazi Anat | Director | 9 | $0 | $0 | 2021-04-15 |
| Toth Christopher A. | SVP and Pres. Oncology Systems | 91 | $0 | $1.67M | 2021-04-15 |
| Balser Jeffrey R. | Director | 12 | $0 | $0 | 2021-04-15 |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controller | 92 | $0 | $5.04M | 2021-04-15 |
| Febbo Phillip G. | Director | 9 | $0 | $0 | 2021-04-15 |
| Hutchinson Michael Damon | SVP,Chief Legal Officer, Secy | 7 | $0 | $0 | 2021-04-15 |
| DUGAN REGINA E | Director | 24 | $0 | $0 | 2021-04-15 |
| KENNEDY KOLLEEN T | SVP and Pres. Oncology Sys. | 488 | $0 | $29.69M | 2021-04-15 |
| WILSON DOW R | President and CEO | 231 | $0 | $138.00M | 2021-04-15 |
| BUTEL JEAN LUC | Director | 19 | $0 | $0 | 2021-04-15 |
| ECKERT R ANDREW | Director | 83 | $0 | $4.00M | 2021-04-15 |
| BRUNER JUDY | Director | 15 | $0 | $0 | 2021-04-15 |
| ILLINGWORTH DAVID J | Director | 38 | $0 | $1.49M | 2021-04-15 |
| Bruff Jesse Michael | SVP Finance, CFO | 36 | $0 | $1.17M | 2021-03-01 |
| KUO JOHN W | VP, Gen Counsel and Secretary | 394 | $0 | $17.51M | 2020-02-18 |
| GUERTIN TIMOTHY E | President and CEO | 149 | $0 | $105.84M | 2020-02-10 |
| BISCHOPING GARY E JR | SVP, Finance & CFO | 34 | $0 | $7.70M | 2019-07-11 |
| BOSTROM SUSAN L | Director | 41 | $0 | $3.21M | 2019-02-12 |
| Baselga Jose | Director | 2 | $0 | $0 | 2018-02-09 |
| LARET MARK R | Director | 46 | $0 | $4.31M | 2018-02-08 |
| FINNEY ELISHA W | SVP, Finance and CFO | 292 | $0 | $43.56M | 2017-02-15 |
| VERHOEF CLARENCE R | SVP, Finance, Corp Controller | 64 | $0 | $1.60M | 2016-11-21 |
| THYAGARAJAN VENKATRAMAN | Director | 40 | $0 | $1.70M | 2016-08-22 |
| NAUMANN-ETIENNE RUEDIGER | Director | 41 | $0 | $3.06M | 2016-06-08 |
| SANYAL SUNNY | SVP and President, ICB | 14 | $0 | $0 | 2016-02-16 |
| REINHARDT ERICH R | Director | 8 | $0 | $0 | 2016-02-16 |
| LEVY RICHARD M | Director | 53 | $0 | $17.66M | 2014-02-03 |
| KLUGE ROBERT H | Corp VP; Pres. X-Ray Products | 51 | $0 | $16.07M | 2013-12-04 |
| BROWN JOHN SEELY | Director | 22 | $0 | $2.51M | 2013-02-14 |
| CHEN TAI-YUN | VP and Corporate Controller | 19 | $0 | $4.81M | 2012-08-10 |
| MARTIN DAVID W JR | Director | 6 | $0 | $0 | 2012-02-09 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Ashkenazi Anat | Director | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,022 | — | $0 | 0 | SEC↗ |
| Le Beau Michelle | Director | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,022 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | D To issuer deriv | 2021-04-15 | 2021-04-16 | 8,437 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | D To issuer deriv | 2021-04-15 | 2021-04-16 | 6,415 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,816 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | D To issuer deriv | 2021-04-15 | 2021-04-16 | 633 | — | $0 | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | D To issuer deriv | 2021-04-15 | 2021-04-16 | 506 | — | $0 | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,641 | — | $0 | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | D To issuer deriv | 2021-04-15 | 2021-04-16 | 6,340 | — | $0 | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,711 | — | $0 | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,059 | — | $0 | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | D To issuer deriv | 2021-04-15 | 2021-04-16 | 2,587 | $112.82 | $291.9K | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | D To issuer deriv | 2021-04-15 | 2021-04-16 | 7,846 | $146.91 | $1.15M | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | D To issuer deriv | 2021-04-15 | 2021-04-16 | 6,859 | $131.77 | $903.8K | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 8,859 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,063 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,630 | $112.82 | $183.9K | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 12,103 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 10,777 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,906 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 6,002 | $131.77 | $790.9K | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 14,122 | $146.91 | $2.07M | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | D To issuer deriv | 2021-04-15 | 2021-04-16 | 5,819 | $112.82 | $656.5K | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | D To issuer deriv | 2021-04-15 | 2021-04-16 | 3,429 | $131.77 | $451.8K | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | D To issuer deriv | 2021-04-15 | 2021-04-16 | 253 | — | $0 | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | D To issuer deriv | 2021-04-15 | 2021-04-16 | 530 | — | $0 | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | D To issuer deriv | 2021-04-15 | 2021-04-16 | 855 | — | $0 | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | D To issuer deriv | 2021-04-15 | 2021-04-16 | 820 | — | $0 | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | D To issuer deriv | 2021-04-15 | 2021-04-16 | 2,017 | — | $0 | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | D To issuer deriv | 2021-04-15 | 2021-04-16 | 3,923 | $146.91 | $576.3K | 0 | SEC↗ |
| Hutchinson Michael Damon | SVP,Chief Legal Officer, Sec | D To issuer deriv | 2021-04-15 | 2021-04-16 | 7,204 | — | $0 | 0 | SEC↗ |
| Febbo Phillip G. | Director | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,022 | — | $0 | 0 | SEC↗ |
| WILSON DOW R | President and CEO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 163,361 | $118.76 | $19.40M | 0 | SEC↗ |
| WILSON DOW R | President and CEO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 21,613 | — | $0 | 0 | SEC↗ |
| WILSON DOW R | President and CEO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 23,577 | — | $0 | 0 | SEC↗ |
| WILSON DOW R | President and CEO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 130,095 | $131.58 | $17.12M | 0 | SEC↗ |
| WILSON DOW R | President and CEO | D To issuer deriv | 2021-04-15 | 2021-04-16 | 20,763 | — | $0 | 0 | SEC↗ |
| ILLINGWORTH DAVID J | Director | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,022 | — | $0 | 0 | SEC↗ |
| BRUNER JUDY | Director | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,022 | — | $0 | 0 | SEC↗ |
| ECKERT R ANDREW | Director | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,022 | — | $0 | 0 | SEC↗ |
| DUGAN REGINA E | Director | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,022 | — | $0 | 0 | SEC↗ |
| BUTEL JEAN LUC | Director | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,022 | — | $0 | 0 | SEC↗ |
| Balser Jeffrey R. | Director | D To issuer deriv | 2021-04-15 | 2021-04-16 | 1,022 | — | $0 | 0 | SEC↗ |
| Ashkenazi Anat | Director | D To issuer | 2021-04-15 | 2021-04-16 | 2,574 | — | $0 | 0 | SEC↗ |
| Le Beau Michelle | Director | D To issuer | 2021-04-15 | 2021-04-16 | 1,333 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | D To issuer | 2021-04-15 | 2021-04-16 | 15,418 | — | $0 | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | D To issuer | 2021-04-15 | 2021-04-16 | 1,556 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | D To issuer | 2021-04-15 | 2021-04-16 | 29,249 | — | $0 | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | D To issuer | 2021-04-15 | 2021-04-16 | 724 | — | $0 | 0 | SEC↗ |
| Hutchinson Michael Damon | SVP,Chief Legal Officer, Sec | D To issuer | 2021-04-15 | 2021-04-16 | 5,589 | — | $0 | 0 | SEC↗ |
| Febbo Phillip G. | Director | D To issuer | 2021-04-15 | 2021-04-16 | 1,699 | — | $0 | 0 | SEC↗ |
| WILSON DOW R | President and CEO | D To issuer | 2021-04-15 | 2021-04-16 | 39,231 | — | $0 | 0 | SEC↗ |
| ILLINGWORTH DAVID J | Director | D To issuer | 2021-04-15 | 2021-04-16 | 15,369 | — | $0 | 0 | SEC↗ |
| BRUNER JUDY | Director | D To issuer | 2021-04-15 | 2021-04-16 | 6,779 | — | $0 | 0 | SEC↗ |
| ECKERT R ANDREW | Director | G Gift | 2021-04-15 | 2021-04-16 | 170 | — | $0 | 13,826 | SEC↗ |
| ECKERT R ANDREW | Director | D To issuer | 2021-04-15 | 2021-04-16 | 13,826 | — | $0 | 0 | SEC↗ |
| DUGAN REGINA E | Director | D To issuer | 2021-04-15 | 2021-04-16 | 12,396 | — | $0 | 0 | SEC↗ |
| BUTEL JEAN LUC | Director | D To issuer | 2021-04-15 | 2021-04-16 | 4,048 | — | $0 | 0 | SEC↗ |
| Balser Jeffrey R. | Director | D To issuer | 2021-04-15 | 2021-04-16 | 2,824 | — | $0 | 0 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | S Sale | 2021-03-01 | 2021-03-03 | 6,499 | $175.81 | $1.14M | 823 | SEC↗ |
| WILSON DOW R | President and CEO | G Gift | 2021-02-22 | 2021-04-16 | 3,398 | — | $0 | 39,087 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | M Exercise deriv | 2021-02-16 | 2021-02-17 | 506 | — | $0 | 506 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | M Exercise deriv | 2021-02-16 | 2021-02-17 | 529 | — | $0 | 1,059 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | M Exercise deriv | 2021-02-16 | 2021-02-17 | 493 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2021-02-16 | 2021-02-17 | 632 | — | $0 | 3,356 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2021-02-16 | 2021-02-17 | 907 | — | $0 | 2,449 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2021-02-16 | 2021-02-17 | 837 | — | $0 | 3,988 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise deriv | 2021-02-16 | 2021-02-17 | 370 | — | $0 | 759 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise deriv | 2021-02-16 | 2021-02-17 | 264 | — | $0 | 277 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise deriv | 2021-02-16 | 2021-02-17 | 253 | — | $0 | 506 | SEC↗ |
| ECKERT R ANDREW | Director | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 0 | SEC↗ |
| Febbo Phillip G. | Director | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 0 | SEC↗ |
| Le Beau Michelle | Director | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,333 | — | $0 | 0 | SEC↗ |
| ILLINGWORTH DAVID J | Director | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 0 | SEC↗ |
| DUGAN REGINA E | Director | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 0 | SEC↗ |
| BUTEL JEAN LUC | Director | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 0 | SEC↗ |
| BRUNER JUDY | Director | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 0 | SEC↗ |
| Balser Jeffrey R. | Director | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 0 | SEC↗ |
| Ashkenazi Anat | Director | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 0 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,062 | — | $0 | 2,304 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2021-02-16 | 2021-02-17 | 953 | — | $0 | 665 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2021-02-16 | 2021-02-17 | 1,241 | — | $0 | 3,366 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2021-02-16 | 2021-02-17 | 422 | — | $0 | 422 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2021-02-16 | 2021-02-17 | 680 | — | $0 | 1,362 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2021-02-16 | 2021-02-17 | 197 | — | $0 | 0 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | M Exercise | 2021-02-16 | 2021-02-17 | 529 | — | $0 | 2,330 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | M Exercise | 2021-02-16 | 2021-02-17 | 506 | — | $0 | 1,801 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | M Exercise | 2021-02-16 | 2021-02-17 | 493 | — | $0 | 1,295 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | F Tax w/h | 2021-02-16 | 2021-02-17 | 848 | $176.15 | $149.4K | 1,482 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | F Tax w/h | 2021-02-16 | 2021-02-17 | 848 | $176.15 | $149.4K | 15,230 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2021-02-16 | 2021-02-17 | 837 | — | $0 | 14,539 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2021-02-16 | 2021-02-17 | 632 | — | $0 | 15,171 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2021-02-16 | 2021-02-17 | 907 | — | $0 | 16,078 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | F Tax w/h | 2021-02-16 | 2021-02-17 | 342 | $176.15 | $60.2K | 621 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise | 2021-02-16 | 2021-02-17 | 370 | — | $0 | 446 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise | 2021-02-16 | 2021-02-17 | 253 | — | $0 | 699 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise | 2021-02-16 | 2021-02-17 | 264 | — | $0 | 963 | SEC↗ |
| ECKERT R ANDREW | Director | M Exercise | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 14,273 | SEC↗ |
| Febbo Phillip G. | Director | M Exercise | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 1,699 | SEC↗ |
| Le Beau Michelle | Director | M Exercise | 2021-02-16 | 2021-02-17 | 1,333 | — | $0 | 1,333 | SEC↗ |
| ILLINGWORTH DAVID J | Director | M Exercise | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 15,369 | SEC↗ |
| DUGAN REGINA E | Director | M Exercise | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 12,396 | SEC↗ |
| BUTEL JEAN LUC | Director | M Exercise | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 4,415 | SEC↗ |
| BUTEL JEAN LUC | Director | F Tax w/h | 2021-02-16 | 2021-02-17 | 367 | $176.15 | $64.6K | 4,048 | SEC↗ |
| BRUNER JUDY | Director | M Exercise | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 6,779 | SEC↗ |
| Balser Jeffrey R. | Director | M Exercise | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 2,824 | SEC↗ |
| Ashkenazi Anat | Director | M Exercise | 2021-02-16 | 2021-02-17 | 1,225 | — | $0 | 2,574 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2021-02-16 | 2021-02-17 | 1,062 | — | $0 | 29,421 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2021-02-16 | 2021-02-17 | 953 | — | $0 | 30,374 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | F Tax w/h | 2021-02-16 | 2021-02-17 | 1,118 | $176.15 | $196.9K | 29,256 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2021-02-16 | 2021-02-17 | 1,241 | — | $0 | 28,359 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2021-02-16 | 2021-02-17 | 422 | — | $0 | 7,118 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2021-02-16 | 2021-02-17 | 680 | — | $0 | 7,798 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | F Tax w/h | 2021-02-16 | 2021-02-17 | 476 | $176.15 | $83.8K | 7,322 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2021-02-16 | 2021-02-17 | 197 | — | $0 | 6,696 | SEC↗ |
| Le Beau Michelle | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 1,022 | — | $0 | 1,022 | SEC↗ |
| ILLINGWORTH DAVID J | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 1,022 | — | $0 | 1,022 | SEC↗ |
| Febbo Phillip G. | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 1,022 | — | $0 | 1,022 | SEC↗ |
| ECKERT R ANDREW | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 1,022 | — | $0 | 1,022 | SEC↗ |
| DUGAN REGINA E | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 1,022 | — | $0 | 1,022 | SEC↗ |
| BUTEL JEAN LUC | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 1,022 | — | $0 | 1,022 | SEC↗ |
| BRUNER JUDY | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 1,022 | — | $0 | 1,022 | SEC↗ |
| Director | A Award deriv | 2021-02-11 | 2021-02-16 | 1,022 | — | $0 | 1,022 | SEC↗ | |
| Ashkenazi Anat | Director | A Award deriv | 2021-02-11 | 2021-02-16 | 1,022 | — | $0 | 1,022 | SEC↗ |
| WILSON DOW R | President and CEO | G Gift | 2021-02-08 | 2021-04-16 | 15,460 | — | $0 | 42,485 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise deriv | 2020-12-10 | 2020-12-14 | 4,473 | — | $0 | 0 | SEC↗ |
| WILSON DOW R | President and CEO | G Gift | 2020-12-10 | 2020-12-10 | 16,800 | — | $0 | 104,645 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise | 2020-12-10 | 2020-12-14 | 4,473 | $81.97 | $366.7K | 4,549 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | S Sale | 2020-12-10 | 2020-12-14 | 4,473 | $174.95 | $782.6K | 76 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise deriv | 2020-12-08 | 2020-12-10 | 159,198 | — | $0 | 0 | SEC↗ |
| WILSON DOW R | President and CEO | S Sale | 2020-12-08 | 2020-12-10 | 159,198 | $174.40 | $27.76M | 121,445 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise | 2020-12-08 | 2020-12-10 | 159,198 | $109.03 | $17.36M | 280,643 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise deriv | 2020-12-07 | 2020-12-09 | 111,830 | — | $0 | 0 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise deriv | 2020-12-07 | 2020-12-09 | 75,015 | — | $0 | 0 | SEC↗ |
| WILSON DOW R | President and CEO | S Sale | 2020-12-07 | 2020-12-09 | 75,015 | $174.35 | $13.08M | 121,445 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise | 2020-12-07 | 2020-12-09 | 75,015 | $80.40 | $6.03M | 196,460 | SEC↗ |
| WILSON DOW R | President and CEO | S Sale | 2020-12-07 | 2020-12-09 | 82,500 | $174.35 | $14.38M | 121,445 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise | 2020-12-07 | 2020-12-09 | 111,830 | $81.97 | $9.17M | 203,945 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise deriv | 2020-12-04 | 2020-12-08 | 6,064 | — | $0 | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise deriv | 2020-12-04 | 2020-12-08 | 8,266 | — | $0 | 0 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | S Sale | 2020-12-04 | 2020-12-08 | 547 | $174.47 | $95.4K | 76 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise | 2020-12-04 | 2020-12-08 | 6,064 | $67.12 | $407.0K | 7,719 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | S Sale | 2020-12-04 | 2020-12-08 | 6,064 | $174.41 | $1.06M | 1,655 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise | 2020-12-04 | 2020-12-08 | 8,266 | $80.40 | $664.6K | 9,921 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | S Sale | 2020-12-04 | 2020-12-08 | 8,266 | $174.51 | $1.44M | 1,655 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | S Sale | 2020-12-04 | 2020-12-08 | 1,032 | $174.47 | $180.1K | 623 | SEC↗ |
| ECKERT R ANDREW | Director | G Gift | 2020-12-02 | 2021-04-16 | 277 | — | $0 | 12,771 | SEC↗ |
| Hutchinson Michael Damon | SVP,Chief Legal Officer, Sec | M Exercise deriv | 2020-12-01 | 2020-12-03 | 11,014 | — | $0 | 0 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2020-12-01 | 2020-12-03 | 5,716 | — | $0 | 0 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2020-12-01 | 2020-12-03 | 3,750 | — | $0 | 0 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2020-12-01 | 2020-12-03 | 1,035 | — | $0 | 0 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2020-12-01 | 2020-12-03 | 10,465 | — | $0 | 0 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2020-12-01 | 2020-12-03 | 10,087 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2020-12-01 | 2020-12-03 | 11,594 | — | $0 | 4,825 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2020-12-01 | 2020-12-03 | 13,450 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2020-12-01 | 2020-12-03 | 4,823 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2020-12-01 | 2020-12-03 | 8,573 | — | $0 | 0 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2020-12-01 | 2020-12-03 | 8,794 | — | $0 | 0 | SEC↗ |
| Hutchinson Michael Damon | SVP,Chief Legal Officer, Sec | F Tax w/h | 2020-12-01 | 2020-12-03 | 5,425 | $174.19 | $945.0K | 5,589 | SEC↗ |
| Hutchinson Michael Damon | SVP,Chief Legal Officer, Sec | M Exercise | 2020-12-01 | 2020-12-03 | 11,014 | — | $0 | 11,014 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2020-12-01 | 2020-12-03 | 1,035 | $112.82 | $116.8K | 3,826 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2020-12-01 | 2020-12-03 | 10,087 | $146.91 | $1.48M | 15,790 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2020-12-01 | 2020-12-03 | 10,465 | $107.32 | $1.12M | 14,142 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | F Tax w/h | 2020-12-01 | 2020-12-03 | 5,014 | $174.19 | $873.4K | 3,677 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | F Tax w/h | 2020-12-01 | 2020-12-03 | 9,291 | $174.19 | $1.62M | 6,499 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | F Tax w/h | 2020-12-01 | 2020-12-03 | 8,439 | $174.19 | $1.47M | 5,703 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | F Tax w/h | 2020-12-01 | 2020-12-03 | 2,936 | $174.19 | $511.4K | 2,791 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2020-12-01 | 2020-12-03 | 3,750 | $99.26 | $372.2K | 5,727 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | F Tax w/h | 2020-12-01 | 2020-12-03 | 851 | $174.19 | $148.2K | 2,975 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2020-12-01 | 2020-12-03 | 5,716 | $131.77 | $753.2K | 8,691 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2020-12-01 | 2020-12-03 | 8,794 | $112.82 | $992.1K | 12,974 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | F Tax w/h | 2020-12-01 | 2020-12-03 | 3,514 | $174.19 | $612.1K | 4,180 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2020-12-01 | 2020-12-03 | 4,823 | $80.40 | $387.8K | 7,694 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | F Tax w/h | 2020-12-01 | 2020-12-03 | 5,748 | $174.19 | $1.00M | 13,702 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2020-12-01 | 2020-12-03 | 11,594 | — | $0 | 19,450 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | F Tax w/h | 2020-12-01 | 2020-12-03 | 12,388 | $174.19 | $2.16M | 7,856 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2020-12-01 | 2020-12-03 | 13,450 | $146.91 | $1.98M | 20,244 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | F Tax w/h | 2020-12-01 | 2020-12-03 | 7,521 | $174.19 | $1.31M | 6,794 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2020-12-01 | 2020-12-03 | 8,573 | $131.77 | $1.13M | 14,315 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | F Tax w/h | 2020-12-01 | 2020-12-03 | 7,232 | $174.19 | $1.26M | 5,742 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-11-24 | 2020-11-25 | 4,288 | $174.15 | $746.8K | 27,118 | SEC↗ |
| WILSON DOW R | President and CEO | A Award | 2020-11-23 | 2020-11-25 | 18,952 | — | $0 | 101,516 | SEC↗ |
| WILSON DOW R | President and CEO | F Tax w/h | 2020-11-23 | 2020-11-25 | 9,401 | $173.50 | $1.63M | 92,115 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | F Tax w/h | 2020-11-23 | 2020-11-25 | 4,225 | $173.50 | $733.0K | 31,406 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | A Award | 2020-11-23 | 2020-11-25 | 8,513 | — | $0 | 35,631 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | F Tax w/h | 2020-11-23 | 2020-11-25 | 667 | $173.50 | $115.7K | 2,871 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | A Award | 2020-11-23 | 2020-11-25 | 1,914 | — | $0 | 3,538 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | A Award | 2020-11-23 | 2020-11-25 | 844 | — | $0 | 1,952 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | F Tax w/h | 2020-11-23 | 2020-11-25 | 297 | $173.50 | $51.5K | 1,655 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | F Tax w/h | 2020-11-23 | 2020-11-25 | 410 | $173.50 | $71.1K | 802 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | A Award | 2020-11-23 | 2020-11-25 | 1,126 | — | $0 | 1,212 | SEC↗ |
| WILSON DOW R | President and CEO | A Award deriv | 2020-11-21 | 2020-12-10 | 159,198 | $109.03 | $17.36M | 159,198 | SEC↗ |
| WILSON DOW R | President and CEO | A Award deriv | 2020-11-20 | 2020-11-24 | 21,613 | — | $0 | 21,613 | SEC↗ |
| O'Reilly Kevin | SVP, President of Oncology S | A Award deriv | 2020-11-20 | 2020-11-24 | 6,340 | — | $0 | 6,340 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | A Award deriv | 2020-11-20 | 2020-11-24 | 2,017 | — | $0 | 2,017 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | A Award deriv | 2020-11-20 | 2020-11-24 | 12,103 | — | $0 | 12,103 | SEC↗ |
| Hutchinson Michael Damon | SVP,Chief Legal Officer, Sec | A Award deriv | 2020-11-20 | 2020-11-24 | 7,204 | — | $0 | 7,204 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-11-16 | 2020-11-18 | 400 | — | $0 | 6,002 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-11-16 | 2020-11-18 | 400 | $173.70 | $69.5K | 27,118 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-11-16 | 2020-11-18 | 400 | $131.77 | $52.7K | 27,518 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-11-09 | 2020-11-10 | 543 | — | $0 | 1,630 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-11-09 | 2020-11-10 | 543 | $173.79 | $94.4K | 27,118 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-11-09 | 2020-11-10 | 543 | $112.82 | $61.3K | 27,661 | SEC↗ |
| WILSON DOW R | President and CEO | G Gift | 2020-11-05 | 2021-04-16 | 46,700 | — | $0 | 35,864 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-10-14 | 2020-10-16 | 400 | — | $0 | 6,402 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-10-14 | 2020-10-16 | 400 | $131.77 | $52.7K | 27,518 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-10-14 | 2020-10-16 | 400 | $172.01 | $68.8K | 27,118 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-10-08 | 2020-10-09 | 543 | — | $0 | 2,173 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-10-08 | 2020-10-09 | 543 | $112.82 | $61.3K | 27,661 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-10-08 | 2020-10-09 | 543 | $171.91 | $93.3K | 27,118 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise deriv | 2020-09-21 | 2020-09-23 | 38,907 | — | $0 | 0 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise | 2020-09-21 | 2020-09-23 | 38,907 | $67.12 | $2.61M | 121,471 | SEC↗ |
| WILSON DOW R | President and CEO | S Sale | 2020-09-21 | 2020-09-23 | 38,907 | $172.43 | $6.71M | 82,564 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-09-14 | 2020-09-16 | 400 | — | $0 | 6,802 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-09-14 | 2020-09-16 | 400 | $131.77 | $52.7K | 27,518 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-09-14 | 2020-09-16 | 400 | $173.48 | $69.4K | 27,118 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-09-08 | 2020-09-10 | 543 | — | $0 | 2,716 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-09-08 | 2020-09-10 | 543 | $112.82 | $61.3K | 27,661 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-09-08 | 2020-09-10 | 543 | $173.60 | $94.3K | 27,118 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise deriv | 2020-08-21 | 2020-08-24 | 38,907 | — | $0 | 38,907 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | A Award deriv | 2020-08-21 | 2020-08-24 | 11,594 | — | $0 | 11,594 | SEC↗ |
| Hutchinson Michael Damon | SVP,Chief Legal Officer, Sec | A Award deriv | 2020-08-21 | 2020-08-24 | 11,014 | — | $0 | 11,014 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise | 2020-08-21 | 2020-08-24 | 38,907 | $67.12 | $2.61M | 121,471 | SEC↗ |
| WILSON DOW R | President and CEO | S Sale | 2020-08-21 | 2020-08-24 | 38,907 | $172.63 | $6.72M | 82,564 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-08-14 | 2020-08-19 | 400 | — | $0 | 7,202 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-08-14 | 2020-08-19 | 400 | $131.77 | $52.7K | 27,518 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-08-14 | 2020-08-19 | 400 | $173.18 | $69.3K | 27,118 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-08-10 | 2020-08-12 | 543 | — | $0 | 3,259 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-08-10 | 2020-08-12 | 6,801 | — | $0 | 7,602 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2020-08-10 | 2020-08-12 | 840 | — | $0 | 0 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2020-08-10 | 2020-08-12 | 776 | — | $0 | 1,553 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-08-10 | 2020-08-12 | 543 | $112.82 | $61.3K | 34,462 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-08-10 | 2020-08-12 | 6,801 | $131.77 | $896.2K | 33,919 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-08-10 | 2020-08-12 | 6,801 | $173.31 | $1.18M | 27,661 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-08-10 | 2020-08-12 | 543 | $173.31 | $94.1K | 27,118 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2020-08-10 | 2020-08-12 | 776 | — | $0 | 2,535 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | F Tax w/h | 2020-08-10 | 2020-08-12 | 558 | $173.33 | $96.7K | 1,977 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2020-08-10 | 2020-08-12 | 840 | — | $0 | 1,759 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-07-29 | 2020-07-31 | 2,716 | — | $0 | 3,802 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-07-29 | 2020-07-31 | 2,716 | $135.00 | $366.7K | 27,118 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-07-29 | 2020-07-31 | 2,716 | $112.82 | $306.4K | 29,834 | SEC↗ |
| ECKERT R ANDREW | Director | G Gift | 2020-05-22 | 2021-02-17 | 50 | — | $0 | 13,048 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | S Sale | 2020-05-07 | 2020-05-11 | 205 | $117.22 | $24.0K | 919 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | S Sale | 2020-04-13 | 2020-04-15 | 996 | $109.33 | $108.9K | 2,253 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | S Sale | 2020-04-13 | 2020-04-15 | 510 | $110.18 | $56.2K | 1,743 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | S Sale | 2020-04-13 | 2020-04-15 | 119 | $111.28 | $13.2K | 1,624 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise deriv | 2020-03-17 | 2020-03-18 | 38,909 | — | $0 | 77,814 | SEC↗ |
| WILSON DOW R | President and CEO | S Sale | 2020-03-17 | 2020-03-18 | 38,909 | $110.00 | $4.28M | 82,358 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise | 2020-03-17 | 2020-03-18 | 38,909 | $67.12 | $2.61M | 121,267 | SEC↗ |
| BUTEL JEAN LUC | Director | M Exercise deriv | 2020-03-02 | 2020-03-04 | 1,871 | — | $0 | 0 | SEC↗ |
| BUTEL JEAN LUC | Director | F Tax w/h | 2020-03-02 | 2020-03-04 | 561 | $126.55 | $71.0K | 3,190 | SEC↗ |
| BUTEL JEAN LUC | Director | M Exercise | 2020-03-02 | 2020-03-04 | 1,871 | — | $0 | 3,751 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-02-19 | 2020-02-21 | 2,034 | $147.32 | $299.6K | 27,118 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | S Sale | 2020-02-19 | 2020-02-21 | 619 | $146.77 | $90.9K | 29,152 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | S Sale | 2020-02-19 | 2020-02-21 | 820 | $147.32 | $120.8K | 897 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | S Sale | 2020-02-19 | 2020-02-21 | 270 | $146.80 | $39.6K | 1,717 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise deriv | 2020-02-18 | 2020-02-20 | 253 | — | $0 | 541 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise deriv | 2020-02-18 | 2020-02-20 | 369 | — | $0 | 1,129 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise deriv | 2020-02-18 | 2020-02-20 | 1,106 | — | $0 | 1,498 | SEC↗ |
| KUO JOHN W | SVP, Gen Counsel and Secreta | M Exercise deriv | 2020-02-18 | 2020-02-20 | 798 | — | $0 | 2,847 | SEC↗ |
| KUO JOHN W | SVP, Gen Counsel and Secreta | M Exercise deriv | 2020-02-18 | 2020-02-20 | 683 | — | $0 | 2,164 | SEC↗ |
| KUO JOHN W | SVP, Gen Counsel and Secreta | M Exercise deriv | 2020-02-18 | 2020-02-20 | 1,120 | — | $0 | 3,645 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2020-02-18 | 2020-02-20 | 968 | — | $0 | 3,571 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2020-02-18 | 2020-02-20 | 632 | — | $0 | 1,254 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise deriv | 2020-02-18 | 2020-02-20 | 837 | — | $0 | 1,886 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-02-18 | 2020-02-20 | 1,241 | — | $0 | 1,618 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-02-18 | 2020-02-20 | 1,062 | — | $0 | 4,607 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise deriv | 2020-02-18 | 2020-02-20 | 1,684 | — | $0 | 5,669 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise deriv | 2020-02-18 | 2020-02-20 | 5,017 | — | $0 | 0 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2020-02-18 | 2020-02-20 | 421 | — | $0 | 844 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise deriv | 2020-02-18 | 2020-02-20 | 197 | — | $0 | 197 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise | 2020-02-18 | 2020-02-20 | 253 | — | $0 | 2,256 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise | 2020-02-18 | 2020-02-20 | 369 | — | $0 | 2,625 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | F Tax w/h | 2020-02-18 | 2020-02-20 | 638 | $145.90 | $93.1K | 1,987 | SEC↗ |
| MOMSEN MAGNUS | SVP, CAO, Corporate Controll | M Exercise | 2020-02-18 | 2020-02-20 | 1,106 | — | $0 | 2,003 | SEC↗ |
| KUO JOHN W | SVP, Gen Counsel and Secreta | M Exercise | 2020-02-18 | 2020-02-20 | 683 | — | $0 | 41,160 | SEC↗ |
| KUO JOHN W | SVP, Gen Counsel and Secreta | F Tax w/h | 2020-02-18 | 2020-02-20 | 891 | $145.90 | $130.0K | 40,269 | SEC↗ |
| KUO JOHN W | SVP, Gen Counsel and Secreta | M Exercise | 2020-02-18 | 2020-02-20 | 1,120 | — | $0 | 39,679 | SEC↗ |
| KUO JOHN W | SVP, Gen Counsel and Secreta | M Exercise | 2020-02-18 | 2020-02-20 | 798 | — | $0 | 40,477 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2020-02-18 | 2020-02-20 | 632 | — | $0 | 4,122 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | F Tax w/h | 2020-02-18 | 2020-02-20 | 873 | $145.90 | $127.4K | 3,249 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2020-02-18 | 2020-02-20 | 968 | — | $0 | 2,653 | SEC↗ |
| Toth Christopher A. | SVP and Pres. Oncology Syste | M Exercise | 2020-02-18 | 2020-02-20 | 837 | — | $0 | 3,490 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-02-18 | 2020-02-20 | 1,241 | — | $0 | 30,043 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-02-18 | 2020-02-20 | 1,062 | — | $0 | 31,105 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | F Tax w/h | 2020-02-18 | 2020-02-20 | 1,334 | $145.90 | $194.6K | 29,771 | SEC↗ |
| KENNEDY KOLLEEN T | Pres. Proton Solutions, CGO | M Exercise | 2020-02-18 | 2020-02-20 | 1,684 | — | $0 | 28,802 | SEC↗ |
| WILSON DOW R | President and CEO | M Exercise | 2020-02-18 | 2020-02-20 | 5,017 | — | $0 | 83,977 | SEC↗ |
| WILSON DOW R | President and CEO | F Tax w/h | 2020-02-18 | 2020-02-20 | 1,619 | $145.90 | $236.2K | 82,358 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2020-02-18 | 2020-02-20 | 197 | — | $0 | 747 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | M Exercise | 2020-02-18 | 2020-02-20 | 421 | — | $0 | 1,168 | SEC↗ |
| Bruff Jesse Michael | SVP Finance, CFO | F Tax w/h | 2020-02-18 | 2020-02-20 | 249 | $145.90 | $36.3K | 919 | SEC↗ |
| Le Beau Michelle | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 1,333 | — | $0 | 1,333 | SEC↗ |
| ILLINGWORTH DAVID J | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 1,225 | — | $0 | 1,225 | SEC↗ |
| ECKERT R ANDREW | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 1,225 | — | $0 | 1,225 | SEC↗ |
| DUGAN REGINA E | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 1,225 | — | $0 | 1,225 | SEC↗ |
| BUTEL JEAN LUC | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 1,225 | — | $0 | 1,225 | SEC↗ |
| BRUNER JUDY | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 1,225 | — | $0 | 1,225 | SEC↗ |
| Balser Jeffrey R. | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 1,225 | — | $0 | 1,225 | SEC↗ |
| Ashkenazi Anat | Director | A Award deriv | 2020-02-14 | 2020-02-19 | 1,225 | — | $0 | 1,225 | SEC↗ |